Frame Therapeutics

Amsterdam, Netherlands Founded: 2018 • Age: 8 yrs Acquired By CureVac
Immunotherapies and personalized vaccines for cancer are developed.

About Frame Therapeutics

Frame Therapeutics is a Healthcare company based in Amsterdam (Netherlands) founded in 2018 by Bob Lowenberg and Dinko Valerio, and was acquired by CureVac in June 2022. Immunotherapies and personalized vaccines for cancer are developed. Frame Therapeutics offers products and services including Web Hosting, Cloud Services, VoIP Telephony, and Custom Software. Its focus areas include Life Sciences, Immunotherapy, Vaccine and Therapeutic.

Company details

Frame Therapeutics was founded in 2018 in Amsterdam, Netherlands, within the biotechnology sector. Personalized vaccines for various cancers are developed, alongside immunotherapies targeting tumor genetics. A patented technology named FramePro is utilized to identify mutations in tumor DNA. Operations focus on advancing these treatments through research and development in oncology.

Key Metrics
  • Latest Funding Round
    $55.11K (USD), Grant

    Jan 2020

  • Investors
    CureVac

    & 2 more

  • Acquired by
    CureVac

    (Jun 2022)

Products & Services of Frame Therapeutics

Frame Therapeutics offers a comprehensive portfolio of products and services, including Web Hosting, Cloud Services, VoIP Telephony, and Custom Software.

Web Hosting
Hosting Services

Provides server space and domain management for websites

Cloud Services
Cloud Computing

Offers remote workspaces and data backups for businesses

VoIP Telephony
Telecommunication

Enables internet-based calling and mobile solutions

Custom Software
Software Development

Develops tailored applications for business needs

Funding Insights of Frame Therapeutics

  • Total Rounds 2
  • Last Round Grant β€” $55,110
  • First Round $55,392

    (Aug 2019)

  • Investors Count 2

All 2 funding rounds of Frame Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2020$55,110Grant––
Aug 2019$55,392Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Frame Therapeutics

Frame Therapeutics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include CureVac, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
mRNA-based therapeutics against cancer and infectious diseases are developed.
2000curevac.comTubingen, Germany
Premium access

Investor details for Frame Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Frame Therapeutics

2 people are tracked at Frame Therapeutics (2 in leadership).

NameRoleGroup
Bob Lowenberg
Co-FounderLeadership
Dinko Valerio
Co-FounderLeadership
Premium access

Complete people profiles for Frame Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Frame Therapeutics

4 dated milestones of Frame Therapeutics across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Frame Therapeutics is founded.
  2. Funding First funding round of $55K.
  3. Funding Latest funding round, Grant, of $55K.
  4. Exit Acquired by CureVac.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Frame Therapeutics

Premium access

Complete news archive for Frame Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Frame Therapeutics

Frame Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Frame Therapeutics is headquartered in Amsterdam, Netherlands.

Frame Therapeutics was founded in 2018 in Amsterdam, Netherlands, within the biotechnology sector. Personalized vaccines for various cancers are developed, alongside immunotherapies targeting tumor genetics. A patented technology named FramePro is utilized to identify mutations in tumor DNA. Operations focus on advancing these treatments through research and development in oncology.

Frame Therapeutics offers Web Hosting, Cloud Services, VoIP Telephony, and Custom Software.

Frame Therapeutics has 3 investors. Key investors include CureVac, European Union, and EIC Fund.

Yes. Frame Therapeutics was acquired by CureVac in June 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available